Luiza R. Sakaniya

Luiza R. Sakaniya

Auto-generated profile, based on publicly available information

Luiza R. Sakaniya

Center for Theoretical Problems of Physico-chemical Pharmacology of the Russian Academy of Sciences

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2021 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
LSL. R. Sakania
L. R. Sakania
Olga MelnichenkoOlga Melnichenko
Olga Melnichenko
IKIrina Korsunskaya
Irina Korsunskaya
Stress has always been one of the triggers of hair loss. The global pandemic of COVID-19 infection has become such a factor for many people. Considering that the pathogenesis of hair loss in this infection has not been sufficiently studied yet, many authors suggest that, as the infection itself and the associated psychoemotional condition and the therapy can cause diffuse thinning of hair and androgenic alopecia. Several studies demonstrate a link between androgens involved in the pathogenesis of COVID-19 and the possible development of androgenic alopecia. Other researchers have observed many cases of telogen hair loss associated with this infection. In our practice, we also encounter diffuse hair thinning, presumably caused by COVID-19. Often, many patients do not consider necessity of consulting with doctor for hair loss. They look for medical help only when self-medication does not give the expected result. After these attempts to independently conduct therapy in some cases patients develop negative attitude towards certain drugs. In such cases, the doctor’s task is to adequately assess the patient’s condition and offer the optimal therapy in each specific case. Often, diffuse hair thinning of a telogen nature, which has arisen against the background of various infections, can be stopped without the help of drugs. The article describes the experience of applying care products with natural and innovative components in the fight against COVID-19-induced alopecia, which can be applied in the practice of a dermatologist.

1 January 2022 in Russian Journal of Clinical Dermatology and Venereology
Verified
Journal Article
Closed access
LSL.R. Sakaniya
L.R. Sakaniya
DMD.R. Mil’dzikhova
D.R. Mil’dzikhova
APA.L. Piruzyan
A.L. Piruzyan
IKIrina Korsunskaya
Irina Korsunskaya
В последние годы увеличивается распространенность среднетяжелых и тяжелых акне, плохо поддающихся стандартной терапии. Растет также уровень резистентности к системным антибиотикам. В связи с этим терапия акне данной группой препаратов становится низкоэффективной. При этом важно отметить, что топические антибиотики остаются надежным средством борьбы с проявлениями акне. В терапии среднетяжелых и тяжелых форм акне все больше специалистов отдают предпочтение назначению системных ретиноидов. Многие врачи отмечают, что в первые месяцы терапии системными ретиноидами может возникнуть феномен обострения. Кроме этого дальнейшая терапия данными препаратами связана с рядом нежелательных явлений и побочных эффектов (ретиноидный дерматит, хейлит и др.), которые могут заставить некоторых пациентов и вовсе отказаться от лечения. В задачу врача входит максимально снизить риски, связанные с приемом системных ретиноидов. Помочь в этом может включение в терапию топических антибиотиков на первом этапе лечения, когда возможно обострение акне, а также применение увлажняющих средств на всем протяжении применения ретиноидов для снижения выраженной сухости кожи, часто сопровождающей терапию изотретиноином. Предлагаемый подход к назначению нисходящих доз системного изотретиноина в сочетании с местным применением раствора клиндамицина и увлажняющим средством позволяет обеспечить высокую приверженность лечению, достичь высоких клинических результатов и длительных сроков ремиссии заболевания. Включение в терапию топического антибиотика позволяет предотвратить развитие феномена обострения, а увлажняющие средства минимизируют выраженную сухость, вызванную приемом системного ретиноида.

18 May 2022 in Medical alphabet
Verified
Journal Article
Closed access
PDF file
LSL. R. Sakaniya
L. R. Sakaniya
IOI. V. Olenich
I. V. Olenich
IKIrina Korsunskaya
Irina Korsunskaya
Sensitive skin is a common condition, affecting about half of the general population. This condition is characterized by a number of unpleasant skin symptoms (tingling, burning, pain, and itching) that occur in response to triggers that usually do not cause such reactions. Severe dryness of the skin is often observed in patients with sensitive skin. Nowadays, treatment of the condition of sensitive dry skin comes down to the use of moisturizing care products. We conducted a study of the clinical effectiveness of moisturizing products, which included 50 volunteers. According to the study data, a signifcant effect was achieved by the 21st day of using moisturizers. However, long-term use for more than 2 months allowed to maintain normal values of corneometric parameters even after cancelation moisturizers.

14 March 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
APA. L. Piruzyan
A. L. Piruzyan
DMD. R. Mildzikhova
D. R. Mildzikhova
LSL. R. Sakaniya
L. R. Sakaniya
IKIrina Korsunskaya
Irina Korsunskaya
Aging, and in particular aging changes in skin, are increasingly giving cause for concern to the mankind, especially given the fact that the life expectancy is extending. Skin aging is not only a problem that concerns skin sagginess, but rather it is a complex problem caused by many factors, from immune deficiency to the lifestyle, which affects both the maintenance of the skin’s barrier function and the well-being of the stem cells that support the organ. The structure and amount of lipids in the stratum corneum changes over time, the epidermis becomes thinner, which leads to decreased barrier function of the skin. These changes also cause increased loss of transepidermal fluid. The aging-associated processes in the dermis lead to a loss of skin elasticity and a decrease in hydration. The increased levels of cytokines and histamine in the skin can cause itching and scratching, which will lead to a further increase in skin inflammation. All this can be manifested by severe xerosis, peeling and other unpleasant symptoms. It is impossible to defeat aging, but to minimize its manifestations is an achievable goal. Our experience allows us to recommend care products with pronounced nutritional and moisturizing properties, which contain panthenol, prebiotics and probiotics, sodium hyaluronate and a natural complex of glycoceramides, cholesterol and phospholipids. Panthenol has a regenerating and softening effect, nourishes and relieves irritation, contributes to the increasing strength of collagen fibres. Sodium hyaluronate is responsible for deep hydration of the skin, improving its tone and elasticity. The ceramide complex compensates for the lack of lipids and helps to retain moisture in the stratum corneum. Regular care helps to minimize xerosis, itching, skin tightness and maintain quality of life in aging patients.

10 July 2025 in Consilium Medicum
Verified
Journal Article
Open access
PDF file
LSLuiza R. Sakaniya
Luiza R. Sakaniya
EDEvgeniya V. Dvoriankova
Evgeniya V. Dvoriankova
ZNZofia A. Niewozinska
Zofia A. Niewozinska
KBKsenia V. Badlueva
Ksenia V. Badlueva
EAEkaterina S. Andrienko
Ekaterina S. Andrienko
НАНевозинская Зофия Анатольевна
Невозинская Зофия Анатольевна
Isotretinoin is a systemic retinoid and a vitamin A derivative. Since the 1980s, it has established itself as a highly effective treatment for severe acne. The drug acts on several pathogenesis links, reduces the size of the sebaceous glands and sebum production, and has an anti-inflammatory and immunomodulatory effect. The dosing regimen may vary, but multiple studies have shown that the best effect is achieved with 0.5–1 mg/kg daily up to a cumulative dose of 120–150 mg/kg per course. The duration of therapy is usually 8–12 months. For 15 years now, we have been using isotretinoin, manufactured using LIDOSE technology (Aknekutan), to treat moderate to severe acne. LIDOSE technology is a significant improvement of the drug, which made it possible to increase its bioavailability and reduce the food effect, which increased the compliance of therapy and reduced the number of relapses. The author’s observations showed that relapses occur several months after the end of the isotretinoin treatment course. Risk groups include patients with a history of gynecological diseases and surgical interventions. It is important to note that the disease has less pronounced clinical manifestations in case of relapse. To minimize the risk of exacerbation, women are recommended to take oral contraceptives in combination with isotretinoin after completing the course of therapy. Topical therapy is usually sufficient for patients after surgery; only in 3% of cases, a short course of isotretinoin may be required. It should be mentioned that isotretinoin therapy may be associated with side effects like dry skin and mucous membranes and, in some cases, a change in liver function tests. However, these side effects are successfully treated with moisturizers and hepatoprotectors, respectively.

7 March 2024 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
DMD. R. Mildzikhova
D. R. Mildzikhova
LSL. R. Sakaniya
L. R. Sakaniya
NTN. G. Tserikidze
N. G. Tserikidze
IKIrina Korsunskaya
Irina Korsunskaya
Often enough, women of reproductive age make medical appointments for problems such as acne and rosacea. Treatment of these diseases in this group of patients has unique features. For example, isotretinoin can only be administered for some indications and in combination with most effective contraceptive methods due to its teratogenicity. Also worth noting is that acne prevalence rates among pregnant women are quite high – up to 43% according to various studies. In fact, symptoms of the disease develop during the second and third trimesters. The choice of therapy for these patients is limited and mainly includes topical drugs. The acne management strategies in women planning pregnancy are similar to that in pregnant women. Foreign studies show the relationship between rosacea and hormonal and reproductive factors. Thus, the disease often develops in premenopause; the risk of developing rosacea is also increased in nulliparous women and women delivering their first and last child at an older age. In our practice, we often prescribe a 1% clindamycin solution as a topical antibiotic. The drug is easy to apply and is not visible on the skin after its use. Absence of drug-induced photosensitivity is a significant advantage of the solution over drugs from other groups, which allows using the drug during periods of high solar activity (in particular, in spring and summer). This is also important for patients with rosacea, as exposure to ultraviolet light is one of the factors known to aggravate the disease. A number of management strategies and treatment algorithm for patients of reproductive age suffering from acne and rosacea that are provided in this work will help physicians to select the optimal and safe treatment with due account for reproductive life plans.